2023 RSNA Clinical Trials Methodology Workshop FACULTY
Todd Alonzo, PhD University of Southern California Los Angeles, CA talonzo@childrensoncologygroup.org Biostatistics, Design and Analysis of Screening and Diagnostic Tests PDG 5
Andriy Bandos, PhD University of Pittsburgh Pittsburgh, PA anb61@pitt.edu Biostatistics, ROC Analysis, Statistical Evaluation of Diagnostic Tests PDG 1
Daniel Barboriak, MD Duke Health Durham, NC daniel.barboriak@duke.edu Neuroradiology PDG 2
Jeffrey Blume, PhD University of Virginia Charlottesville, VA jeffrey.blume@virginia.edu Biostatistics, Clinical Trials, Diagnostic Radiology PDG 4
Patrick Bossuyt, PhD Academic Medical Center, University of Amsterdam Amsterdam, The Netherlands p.m.bossuyt@amc.uva.nl Clinical Epidemiology PDG 4
Ruth Carlos, MD, MS University of Michigan Health System Ann Arbor, MI rcarlos@med.umich.edu Patient-reported Outcomes, Communication, and Decision-making PDG 5
J. Jeffrey Carr, MD, MS Vanderbilt University Medical Center Nashville, TN j.jeffrey.carr@vumc.org Cardiothoracic Radiology and Epidemiology PDG 2
John Chen, MD, PhD Massachusetts General Hospital Boston, MA jwchen@mgh.harvard.edu Neuroradiology PDG 5
Kindra Cooper, JD, MPA, MA, CIP Creighton University Omaha, NB KindraCooper@Creighton.edu Regulatory Compliance, Life Sciences, IRB issues All
Jeffrey Jarvik, MD, MPH Harborview Medical Center/University of Washington Seattle, WA jarvikj@uw.edu Spine and Brain Imaging, Comparative Effectiveness Research, Pragmatic Trials PDG 3
Lale Kostakoglu Shields, MD, MPH UVA Health Charlottesville, VA LK3QF@hscmail.mcc.virginia.edu Nuclear Medicine PDG 1
Janie Lee, MD Seattle Cancer Care Alliance/University of Washington Seattle, WA jmlee58@uw.edu Breast Imaging: Screening and Surveillance PDG 3
Susanna Lee, MD, PhD Massachusetts General Hospital Boston, MA slee0@partners.org Genitourinary Imaging, Female Pelvic Imaging, Gynecologic Cancer Imaging PDG 4
Chaya Moskowitz, PhD Memorial Sloan Kettering Cancer Center New York, NY moskowc1@mskcc.org Biostatistics, Design and Analysis of Screening and Diagnostic Tests PDG 3
Nancy Obuchowski, PhD Cleveland Clinic Cleveland, OH obuchon@ccf.org Biostatistics, Design and Analysis of Screening and Diagnostic Tests PDG 2
Daniel Pryma, MD University of Pennsylvania Medical Center Philadelphia, PA dpryma@pennmedicine.upenn.edu Nuclear Medicine PDG 3
Mitchell Schnall, MD, PhD University of Pennsylvania Medical Center Philadelphia, PA Mitchell.Schnall@pennmedicine.upenn.edu MRI-breast and prostate cancer PDG 1
Anthony Shields, MD, PhD Wayne State University Detroit, MI shieldsa@karmanos.org Medical Oncology, PET Imaging, and Drug Development PDG 4
Michael Soulen, MD University of Pennsylvania Philadelphia, PA Michael.Soulen@uphs.upenn.edu Interventional Oncology PDG 5
James Spies, MD Georgetown University Medical Center Washington, DC spiesj@gunet.georgetown.edu Interventional Radiology PDG 1
Charles R. Thomas, MD Dartmouth-Hitchcock Medical Center Lebanon, NH Charles.R.Thomas@Hitchcock.org Radiation Oncology PDG 2